These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11684947)

  • 21. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
    Sibiude J; Warszawski J; Tubiana R; Dollfus C; Faye A; Rouzioux C; Teglas JP; Ekoukou D; Blanche S; Mandelbrot L
    Clin Infect Dis; 2012 May; 54(9):1348-60. PubMed ID: 22460969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beginning to make progress against HIV.
    Wilfert CM
    N Engl J Med; 1996 Nov; 335(22):1678-80. PubMed ID: 8929367
    [No Abstract]   [Full Text] [Related]  

  • 24. Zidovudine.
    Sperling R
    Infect Dis Obstet Gynecol; 1998; 6(5):197-203. PubMed ID: 9894173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of zidovudine in preventing HIV transmission from mother to infant.
    Balsley J
    Am J Med; 1997 May; 102(5B):45-6. PubMed ID: 9845496
    [No Abstract]   [Full Text] [Related]  

  • 26. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
    Dabis F; Bequet L; Ekouevi DK; Viho I; Rouet F; Horo A; Sakarovitch C; Becquet R; Fassinou P; Dequae-Merchadou L; Welffens-Ekra C; Rouzioux C; Leroy V;
    AIDS; 2005 Feb; 19(3):309-18. PubMed ID: 15718842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of perinatal HIV infection: cause for optimism.
    Lindsay MK
    AIDS Clin Care; 1999 Dec; 11(12):95-7, 99, 102. PubMed ID: 11366712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perinatal transmission of HIV in women receiving zidovudine: abstract and commentary.
    Mofenson LM
    JAMA; 1998 Aug; 280(6):569-70. PubMed ID: 9707153
    [No Abstract]   [Full Text] [Related]  

  • 29. Zidovudine administration during pregnancy and mitochondrial disease in the offspring.
    Tovo PA; Chiapello N; Gabiano C; Zeviani M; Spada M
    Antivir Ther; 2005; 10(6):697-9. PubMed ID: 16218167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AIDS drug trials in Thailand and Uganda.
    Simonds RJ
    Nat Med; 1999 Nov; 5(11):1217. PubMed ID: 10545961
    [No Abstract]   [Full Text] [Related]  

  • 31. Perinatal transmission of HIV-1.
    Wood L
    JAMA; 1996 Oct 23-30; 276(16):1300-1; author reply 1301. PubMed ID: 8861985
    [No Abstract]   [Full Text] [Related]  

  • 32. Special issue on health risks of perinatal exposure to nucleoside reverse transcriptase inhibitors.
    Walker VE; Poirier MC
    Environ Mol Mutagen; 2007; 48(3-4):159-65. PubMed ID: 17358025
    [No Abstract]   [Full Text] [Related]  

  • 33. Thai Red Cross zidovudine donation program to prevent vertical transmission of HIV: the effect of the modified ACTG 076 regimen.
    Thisyakorn U; Khongphatthanayothin M; Sirivichayakul S; Rongkavilit C; Poolcharoen W; Kunanusont C; Bien DD; Phanuphak P
    AIDS; 2000 Dec; 14(18):2921-7. PubMed ID: 11153673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. South Africa: setting the wrong example.
    Nat Med; 1999 Jan; 5(1):1. PubMed ID: 9883818
    [No Abstract]   [Full Text] [Related]  

  • 35. 15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children. DITRAME ANRS 049 Study Group.
    Lancet; 1999 Dec; 354(9195):2050-1. PubMed ID: 10636375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV?
    Nightingale S; Dabis F
    J Trop Pediatr; 2006 Aug; 52(4):235-8. PubMed ID: 16877674
    [No Abstract]   [Full Text] [Related]  

  • 38. Unequal care sustains vertical transmission rate.
    Kasper T
    GMHC Treat Issues; 1999 Feb; 13(2):11-2. PubMed ID: 11366115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.
    Brogly SB; Ylitalo N; Mofenson LM; Oleske J; Van Dyke R; Crain MJ; Abzug MJ; Brady M; Jean-Philippe P; Hughes MD; Seage GR
    AIDS; 2007 May; 21(8):929-38. PubMed ID: 17457086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.
    Taha TE; Kumwenda NI; Gibbons A; Broadhead RL; Fiscus S; Lema V; Liomba G; Nkhoma C; Miotti PG; Hoover DR
    Lancet; 2003 Oct; 362(9391):1171-7. PubMed ID: 14568737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.